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R E S E A R C H A R T I C L E
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Leydig Cell Population Sizes in the Adult Mouse Testis
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Yi Ting Tsai,2 Ian Handel,3 Jean-Luc Pitetti,4 Serge Nef,4 Lee B. Smith,2,5
and Peter J. O’Shaughnessy1
1Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow G61
1QH, United Kingdom; 2Medical Research Council Centre for Reproductive Health, The Queen’s Medical
Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom; 3The Roslin Institute and
Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian EH25 9RG, United Kingdom;
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Sertoli cells regulate differentiation and development of the testis and are essential formaintaining
adult testis function. Tomodel the effects of dysregulating Sertoli cell number during development
or aging, we have used acute diphtheria toxin2mediated cell ablation to reduce Sertoli cell
population size. Results show that the size of the Sertoli cell population that forms during de-
velopment determines the number of germ cells and Leydig cells that will be present in the adult
testis. Similarly, the number of germ cells and Leydig cells that can be maintained in the adult
depends directly on the size of the adult Sertoli cell population. Finally, we have used linear
modeling to generate predictive models of testis cell composition during development and in the
adult based on the size of the Sertoli cell population. This study shows that at all ages the size of the
Sertoli cell population is predictive of resulting testicular cell composition. A reduction in Sertoli cell
number/proliferation at any age will therefore lead to a proportional decrease in germ cell and
Leydig cell numbers, with likely consequential effects on fertility and health. (Endocrinology 158:
2955–2969, 2017)
Development and function of the testes require acomplex orchestration of cell differentiation, pro-
liferation, and communication in both fetal and postnatal
life. Initiation of this cascade is dependent on the action of
Sertoli cells. These cells form in the coelomic epithelium
(1) and go on to induce formation of the seminiferous
tubules and subsequent development of the fetal Leydig
cell population (2). The number of Sertoli cells increases
exponentially during fetal life in mice and humans and
then slows after birth, reaching adult levels by early
puberty (3–5).
Recent cell ablation studies from our group have
shown that during the proliferation phase, Sertoli cells
continue to regulate critical aspects of testis development
(6–9). When Sertoli cells are totally ablated in the neo-
nate, for example, tubule structure is lost, the peritubular
myoid cells dedifferentiate, and subsequent differentia-
tion and development of the adult population of Leydig
cells is severely restricted (9). In the adult, Sertoli cells are
essential for maintenance of spermatogenesis, and abla-
tion of the Sertoli cells in the adult is associated with loss
of germ cells (9). More surprisingly, however, Sertoli cell
ablation in the adult also leads to loss of 70% of the adult
Leydig cell population (8). Sertoli cells therefore act as
central regulators of both testis development and adult
function, so any developmental dysregulation that
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impacts Sertoli cell numbers, in either fetal or postnatal
life, could have notable knock-on effects in other cell
types. This would be likely to affect overall testis function
in adulthood and exacerbate the effects of aging on re-
production and overall health (10–15).
Ablation of a total cell population is a very powerful
technique for looking at control mechanisms in a tissue
(7). With respect to normal development/aging and likely
defects, however, complete loss of one cell type is very
unlikely. More feasibly, reductions in cell numbers may
be expected from a change in proliferation rates or an
increase in apoptosis induced, for example, through
exposure to toxicants in utero or by aging. The mouse
diphtheria toxin (DTX) model of Sertoli cell ablation
described recently (8, 9) provides a unique opportunity to
examine the impact of reducing the size of the Sertoli cell
population by defined amounts at different stages of
development. The major advantages of this system are
that it is acute (i.e., Sertoli cell death occurs within
24 hours) and that it is specific to Sertoli cells (i.e., no off-
target effects on other cell types) (8, 9). It is an advance
over previous correlative studies, because it allows cause-
and-effect relationships to be defined without relying on
specific gene knockout or endocrine modulation (with
potential confounder effects) to alter Sertoli cell numbers.
Using this approach, we demonstrate that the size of
the Sertoli cell population that forms during development
regulates and maintains the overall cellular composition
of the adult testis, defining numbers of germ cells and also
numbers of Leydig cells present in the adult testis. We
have also used these data to train age-category2stratified
linear models of Sertoli cell numbers, which we show can
be used as predictive biomarkers of overall testicular cell
composition in development and in adulthood. Together,
these findings demonstrate that Sertoli cells, and par-
ticularly Sertoli cell number, are key therapeutic targets in
efforts to modulate adult testicular cell populations and
functions in support of lifelong male health.
Materials and Methods
Animals and treatments
All animal studies passed local ethical review and were
conducted with licensed permission under the UK Animal
Scientific Procedures Act (1986), Home Office License No. PPL
70/8804. Mice with Sertoli cell2specific induction of the DTX
receptor (iDTR mice) or Sertoli cell2specific induction of the
DTX A-chain (DTA mice) were generated on mixed back-
grounds as previously described (9). In both groups of mice,
expression of the transgene was under control of anti-Mu¨llerian
hormone (AMH) promoter–Cre; thus, in DTA mice, Sertoli cell
ablation will occur shortly after first expression of AMH, which
occurs at about embryonic day (e) 13.5 (16) (Supplemental
Fig. 1). Neonatal (2 days) or adult (50 days) male iDTR mice
were treated with a single subcutaneous injection of DTX (0.01
to 100 ng) to induce Sertoli cell ablation andwere euthanized up
to 90 days after treatment (Supplemental Fig. 1). Serum was
collected for measurement of luteinizing hormone (LH) and
testosterone levels in each animal.
Stereology
Testes were fixed for 6 hours in Bouin solution and then
stored in 70% ethanol before being embedded in Technovit
7100 resin (Heraeus Kulzer GmbH, Hanau, Germany), cut into
sections (20 mm), and stained with Harris hematoxylin and
eosin. Total testis volume was estimated using the Cavalieri
principle (17), and the optical disector technique (18) was used
to count the number of Leydig cells, Sertoli cells, and germ cells
in each testis. The numerical density of each cell type was es-
timated using an Olympus BX50 microscope fitted with a
motorized stage (Prior Scientific Instruments, Cambridge, UK)
and Stereologer software (Systems Planning Analysis, Alexan-
dria, VA). Each cell type was recognized by its position and
morphology as described previously (8, 19). Mean Leydig cell
volume in each sample was measured using the uniform iso-
tropic random rotator method (20) available within the Ster-
eologer software. Eight lines per cell profile were measured, and
between 150 and 200 cells were sampled per testis. To illustrate
testis histology, semithin 2.5-mm sections were cut from tissues
embedded in resin and stained with hematoxylin and eosin.
Immunohistochemistry
Tissues were fixed in Bouin solution for 6 hours, stored in
70% ethanol, and embedded in paraffin. Sections (5 mm) were
dewaxed in xylene and rehydrated, and antigens were retrieved
in a pressure cooker with 0.01 M of citrate buffer (pH 6.0). To
quench endogenous peroxidase activity, slides were incubated
in 0.3% hydrogen peroxide (volume-to-volume ratio) in Tris-
buffered saline for 30minutes at room temperature. Nonspecific
activity was blocked using the appropriate normal blocking
serum for 30 minutes followed by overnight incubation at 4°C
with the primary antibody diluted in blocking serum. The
primary and secondary antibodies used in this study are detailed
in Supplemental Table 1. After washing, slides were incubated
for 30 minutes at room temperature with the appropriate
secondary antibody. For immunofluorescence, peroxidase-
conjugated secondary antibody was used diluted 1/200 in
blocking serum. Sectionswere incubated for 10minutes at room
temperature with the fluorescein Tyramide Signal Amplification
system (TSA™; PerkinElmer) diluted 1/50 according to the
manufacturer’s instructions. Sections were then counterstained
in Sytox Green (Molecular Probes; Life Technologies, Paisley,
UK) for 10 minutes at room temperature and mounted in
PermaFluor mounting medium (Thermo Fisher Scientific,
Renfrew, UK). Slides were scanned using an LSM 710 confocal
microscope and ZEN 2009 software (Carl Zeiss Ltd, Hert-
fordshire, UK). Sections incubated with no primary antibody
were used as negative controls. To check reproducibility, sec-
tions from at least three different animals in each group were
tested, and sections from vehicle- and DTX-treated animals
were processed simultaneously on the same slide.
RNA extraction, reverse transcription, and real-time
polymerase chain reaction
Levels of specific messenger RNA transcripts were measured
by real-time polymerase chain reaction (PCR). Total RNA was
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extracted from whole testes of each animal using TRIzol (Life
Technologies, Paisley, UK). At the start of the extraction pro-
cess, 5 ng external standard RNA (luciferase) was added to each
sample for normalization of data (21). Reverse transcription,
primer design, and real-time PCRwere carried out as previously
described (22, 23). The real-time PCR studieswere carried out at
an annealing temperature of 63°C, extension at 72°C, and
denaturation at 95°C for 40 cycles. Dissociation curves of the
amplified complementary DNA were run to assess the homo-
geneity of the PCR products and to test for the presence of
primer-dimers. The primers used are shown in Supplemental
Table 1. Data from real-time PCR studies were expressed rel-
ative to added luciferase, which is equivalent to expression
per testis.
Tubule permeability
Testes from iDTRmice were collected 7 days or 30 days after
treatment with DTX at 50 days, and tubule permeability was
tested in vitro as described previously (8).
Hormone assay
Serum testosterone was measured using a commercial kit
(Demeditec Diagnostics GmbH, Kiel, Germany), and serum LH
was measured by enzyme-linked immunosorbent assay as
previously described (24). The interassay coefficient of variation
(CV) for testosterone was 10.9% at 2.5 ng/mL and 8.9% at
6.0 ng/mL, whereas the intra-assay CV was ,8% for 0.1 to
25ng/mL.The interassayCVforLHwas12%at1.2and2.5ng/mL,
whereas the intra-assay CV was ,10% for 0.1 to 10 ng/mL.
Statistics
Data sets were analyzed using general linearmodeling.When
this showed a significant overall difference, the significance of
difference between individual groups was determined by t tests
using the pooled variance. When appropriate, data were logged
to avoid heterogeneity of variance. Initial correlations between
data sets were analyzed using the Pearson correlation coefficient
except when data were visually assessed to differ markedly
from a bivariate normal distribution; in that case, Spearman
rank correlation was used instead, with P value calculated by a
randomization test. Discriminant analysis was also used to
analyze germ cell data. Analysis was carried out using Minitab
15 (Minitab Ltd, Coventry, UK) or Graph Prism version 5
(GraphPad Software Inc., San Diego, CA). No differences were
observed between adult control iDTR animals treated with
vehicle as neonates and those treated as adults, and results from
these animals were combined when appropriate. Sertoli cell and
Leydig cell numbers in adult controls fromDTA and iDTRmice
were significantly different and were treated separately for
analysis. This difference probably arises from differences in the
background of the two colonies.
To predict adult testicular cell composition, specifically
Leydig cell counts and germ cell counts, we evaluated a range of
linear models fitted to the data (DTX-treated mice). Candidate
models included terms for Sertoli cell count and additional terms
for the square root and/or the square of the count. We assessed
age as a continuous predictor and as a categorical variable. We
considered age as a category because we expected a discon-
tinuous age effect. In total, three age categories were used:
prepubertal (,21 days); pubertal (21 to 60 days for Leydig cell
prediction and 21 to 45 days for germ cell prediction), and adult
(.60 and .45 days for Leydig cell prediction and germ cell
prediction, respectively). Each age category included all animals
euthanized at that age, irrespective of when Sertoli cell
ablation occurred. We also tested first-order interactions be-
tween the Sertoli cell counts (and their squares and square roots)
and the age category to allow coefficients for these variables to
vary by age group. Models were selected to minimize small
sample-corrected Akaike Information Criteria (23), a parameter
count penalized measure of model fit, aiming to identify the best
predictive model and reduce the risk of overfitting. Linear
modeling assumptions were assessed by graphical examination
of model residuals for approximate normality and hetero-
scedasticity, with the provision to log transform dependent
variables (Sertoli cell count and germ cell count) when residuals
were heteroscedastic. Best-fittingmodels of Leydig cell and germ
cell counts are presented as estimated parameters and formulae
for eachmouse age class and graphically plotted against the Sertoli
cell counts by age group. We assessed the models’ predictive
performance using leave-one-out cross-validation—sequentially
holding back data from one mouse at a time, reestimating the best
model on the remaining data, and using the resulting model to
predict the cell count for the held-back animal. The R statistical
system (version 3.3.1; 2016-06-21) (25) was used for the devel-
opment of the linear models, the analysis of their results (packages
AICcmodavg and tidyverse), and randomization tests for Spear-
man correlation coefficients (coin package).
Results
Sertoli cell population size is reduced in DTA mice
and can be selectively reduced in iDTR mice by DTX
injection in a dose-dependent manner
To assess the impact of defined reductions in Sertoli
cell numbers on testis development and function, we first
sought to establish predictable models correlating ex-
posure to DTX to Sertoli cell number. Because DTX does
not cross the placenta, for prenatal reductions in Sertoli
cell number we again exploited the Sertoli cell-specific
Amh-Cre:DTA (DTA) mouse line, in which expression of
DTA is controlled by Cre-mediated induction of DTA
gene expression, leading to Sertoli cell death. We pre-
viously reported that a proportion of DTA mice showed
only partial ablation of the Sertoli cell population in utero
(9), and these animals were now suitable for our study of
the effects of reduced Sertoli cell number in fetal life. To
determine whether it is possible to induce partial ablation
of the Sertoli cell population in the neonate or in
adulthood in a controlled fashion, the effects of different
doses of DTX were tested using Amh-Cre:DTR (iDTR)
mice (which exclusively express the receptor for DTX in
Sertoli cells) (Fig. 1). In neonatal mice (aged 2 days),
treatment with 1 ng DTX caused a variable ;50% re-
duction in Sertoli cell numbers when examined on day 9,
whereas 10 ng caused complete Sertoli cell ablation
[Fig. 1(a)]. Preliminary studies indicated that sub-
cutaneous injection of adult mice with 1 ng DTX had no
effect on Sertoli cell number [Fig. 1(b)], but more detailed
studies showed that both 10 and 25 ng caused a clear,
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variable (mean, ;50%) reduction in cell numbers (ap-
parent 7 days after injection [Supplemental Fig. 2(a)]),
whereas injection of 50 ng DTX caused complete Sertoli
cell ablation [Fig. 1(b)]. After partial ablation of the
Sertoli cell population in the neonate, testis volume did
not differ from that of controls until day 80 [Supple-
mental Fig. 2(b)]. Reducing Sertoli cell numbers in the
adult reduced testis volume in parallel with changes in
Sertoli cell number after 7 days [Supplemental Fig. 2(c)].
For subsequent studies, neonatal animals were treated
with 1 ng DTX and adults were treated with 10 or 25 ng
DTX to induce a partial reduction in Sertoli cell numbers.
The variable response between animals means that in
most cases, data from individual animals are shown in the
following studies.
Sertoli cell number does not recover after partial
ablation during development or in adulthood
Sertoli cells undergo intense proliferation in fetal and
early postnatal life (26, 27). To determine whether ho-
meostatic mechanisms regulate Sertoli cell population
size during this period to compensate for a reduction in
cell number [as suggested (28)], we tracked the number of
Sertoli cells in the testis after an induced reduction in
either fetal (e16.5) or neonatal life (day 2). Sertoli cell
numbers in control animals increased from e16.5 to reach
their maximum at postnatal day 9 and remained at that
level until adulthood [Fig. 2(a)]. In contrast, in DTAmice,
which undergo partial ablation of the Sertoli cell pop-
ulation in fetal life, Sertoli cell number was significantly
reduced at e16.5 to between 5% and 12% of that of
controls [Fig. 2(a)]. Cross sections taken from the testes of
these mice at e16.5 contained a reduced number of tubular
sections (as low as one in some animals), indicating a
reduced number of tubules [Fig. 2(b)]. Sertoli cell number
did not increase between e16.5 and birth in DTA mice,
although numbers did increase significantly from birth to
day 25 and increased significantly again to adulthood
(relative to day 25) [Fig. 2(a)]. However, Sertoli cell
numbers in DTA mice were significantly reduced com-
pared with those of control animals at all ages. In iDTR
mice treated with 1 ng DTX on day 2 (partial neonatal
Sertoli cell ablation), Sertoli cell numbers were normal on
day 3 but were significantly reduced on day 9 and
remained significantly reduced in adulthood [Fig. 2(a)],
indicating little or no recovery in cell numbers during this
period. Levels of the Sertoli cell2specific messenger RNA
transcripts Sox9 and Wt1 reflected Sertoli cell numbers
after fetal or neonatal ablation of the cells [Fig. 2(c)].
To determine whether the continued increase in Sertoli
cell number in DTA mice beyond 25 days was associated
with retained expression of the immature Sertoli cell
markerAmh, levels ofAmh per Sertoli cell weremeasured
in these mice (Supplemental Fig. 3). Results showed that
adult Amh levels per Sertoli cell were not significantly
different in DTA mice compared to control. Similarly,
other markers of Sertoli cell development (Sox9 and
Cst12) did not differ between groups, although expres-
sion ofRhox5was significantly increased in DTAmice at
birth and was reduced in adulthood (Supplemental
Fig. 3). As expected, there was no recovery in Sertoli cell
number for up to 90 days after partial ablation of Sertoli
cells in adulthood [Supplemental Fig. 2(a)]. Loss of Sertoli
cells by treatment of adult animals with DTX was
Figure 1. Changes in Sertoli cell number after treatment with different doses of DTX. (a) Neonatal (2 days) or (b) adult (50 days) iDTR mice were
injected subcutaneously with different doses of DTX, and Sertoli cell numbers were measured when the animals were (a) 9 days old (7 days after
injection) or (b) 80 days old (30 days after injection). Sertoli cell numbers for individual animals are shown. Differences between groups are
shown by the letters above each group; groups that do not share a common letter are significantly different. Examples of hematoxylin and
eosin2stained sections from different groups of animals treated with DTX (a) as neonates or (b) as adults are shown above each graph. The bars
represent 100 mm.
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accompanied by focal disruption to
the blood2testis barrier (BTB), although
most tubules appeared to maintain a
viable BTB, suggesting that the remain-
ing Sertoli cells are able to reestab-
lish functional cell-cell junctions
(Fig. 3).
Together, these data argue against
the existence of a regulatory mecha-
nism within the testis that changes
Sertoli cell proliferation to rescue any
shortfall in numbers.
Total germ cell numbers and
composition in adulthood are
dependent on the number of
Sertoli cells that form
during development
Previous studies have demonstrated a
correlation between Sertoli cell numbers
and spermatid numbers (29–32), but it
is unknown whether this applies
across germ cell types. We took this
opportunity to empirically examine
the relationship between Sertoli cell
population size and germ cell number
in greater detail using our models,
which are independent of gene knock-
out or endocrine modulation.
After partial ablation of the Sertoli
cell population in the fetus, a propor-
tion of the few tubules that remained
in the adult had clearly disrupted sper-
matogenesis [Fig. 2(b), asterisk], al-
though spermatogenesis in other tubules
appeared largely normal. Partial abla-
tion of the Sertoli cell population in
the neonate reduced adult tubule di-
ameter, but ongoing spermatogenesis
was apparent in most tubules [Fig. 2(b)]
with qualitatively normal spermato-
genesis and an absence of germ cell2
free tubules.
Total numbers of germ cells were
static from e16.5 to birth and then
increased continuously to adulthood in
control animals [Fig. 4(a)]. Gonocyte
number was significantly reduced at
e16.5 after partial ablation of the
Sertoli cell population in fetal life and
did not change significantly up to birth
[Fig. 4(a)]. Gonocytes were seen only in
the tubules of control mice but were
Figure 2. Effects of Sertoli cell ablation on Sertoli cell number, morphology, and transcript
levels in the fetus and neonate. (a) Combined data from studies on fetal and neonatal Sertoli
cell ablation show changes in Sertoli cell number in each group from e16.5 to adulthood. (b)
Testis morphology during development in control mice (WT), DTA mice, and iDTR mice
treated as neonates (2 days) with 1 ng DTX or with vehicle. Sections are shown from animals
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present in both the tubules and the interstitium of the
testes at e16.5 and at birth in DTA mice (Supplemental
Fig. 4). After birth, there was a marked increase in germ
cell numbers up to day 80 in DTA mice, though this
remained significantly less than numbers of germ cells in
control animals [note log scale in Fig. 4(a)]. After an
induced reduction in Sertoli cell numbers in the neonate,
mean germ cell numbers were not significantly different
from those of controls at any later age.
The germ cell/Sertoli cell ratio (an indication of the
number of germ cells supported by each Sertoli cell)
decreased in control animals between e16.5 and day
0 (because of the relatively greater increase in Sertoli cell
number between these ages). The ratio then increased
after day 3, reaching a maximum at day 80 [Fig. 4(b)].
After partial ablation of the Sertoli cell population at
e16.5, the germ cell/Sertoli cell ratio was significantly
greater than that of control animals at e16.5 and day
0 but was the same as that of controls on days 25 and 80.
The germ cell/Sertoli cell ratio was normal at all ages after
neonatal ablation of Sertoli cells [Fig. 4(b)].
Analysis of all data points from all groups revealed a
significant correlation (r = 0.800; P , 0.001) between
total germ cell number in adulthood and size of the Sertoli
cell population that formed during development [Fig.
4(c)], demonstrating that Sertoli cell number is a pre-
dictable biomarker of total germ cell number under
nonpathological conditions.
A marked reduction in Sertoli cell numbers in the
adult is required to alter the germ cell/Sertoli
cell ratio
Partial ablation of the Sertoli cell population at day 50
reduced tubule diameter 30 days later, but ongoing
spermatogenesis was apparent in most tubules [Fig. 1(b)].
However, this spermatogenesis appeared abnormal, and
it was not possible to categorize normal spermatogenic
stages in most tubules. Most animals contained some
tubules that were largely germ cell free [Fig. 1(b), 25 ng],
and the numbers of these tubules increased in animals
with greater levels of Sertoli cell ablation.
Total germ cell numbers were again closely correlated
to Sertoli cell numbers after an induced reduction of
Sertoli cell numbers in the adult [Fig. 4(d)] (r = 0.915; P,
0.001). This relationship was also apparent when indi-
vidual germ cell types (spermatogonia, spermatocytes,
round spermatids, and elongated spermatids) were
plotted against Sertoli cell numbers [Supplemental Fig.
5(a)]. Similarly, the total germ cell/Sertoli cell ratio was
dependent on Sertoli cell number, but discriminant
analysis showed the presence of two distinct groupings
[Fig. 4(e)]. These two groupings were also present when
total germ cell numbers were subdivided into sper-
matocytes, round spermatids, and elongated spermatids
[Supplemental Fig. 5(b)]. In these germ cell types, the
germ cell/Sertoli cell ratio remained normal with de-
clining Sertoli cell numbers until Sertoli cell numbers
decreased below 60% to 65%of normal. Below this level,
the germ cell/Sertoli cell ratio declined toward zero as
Sertoli cell numbers decreased. Spermatogonial cell
number per Sertoli cell appeared to show a different
pattern of response to declining Sertoli cell number, with
the ratio remaining normal or close to normal even when
80% of Sertoli cells were lost [Supplemental Fig. 5(b)].
Leydig cell number is highly correlated with Sertoli
cell number
During development, Leydig cell numbers did not
change significantly in control animals between e16.5
and day 3 but then increased through puberty reaching a
maximum by day 80 [Fig. 5(a)]. Partial ablation of the
Sertoli cell population in fetal life (DTA mice) reduced
Leydig cell numbers at all ages up to day 80 [Fig. 5(a)].
Partial neonatal ablation of the Sertoli cell population
had no significant effect on Leydig cell numbers up to day
25, but it significantly reduced Leydig cell numbers in
adulthood [Fig. 5(a)]. Transcript expression of the Leydig
cell markers Star and Hsd3b6 largely paralleled changes
in Leydig cell numbers [Fig. 5(b)], although there was no
difference in transcript levels between control animals
and animals treated with DTX as neonates (neonate
ablation).
When data from fetal and neonatal Sertoli cell ablation
studies were combined, there was a very strong corre-
lation (r = 0.929; P, 0.001) between numbers of Sertoli
and Leydig cells in adulthood [Fig. 5(c)]. This means that
the number of Leydig cells in the adult testis could be
clearly predicted from the number of Sertoli cells that
formed during development. A clear correlation (r = 0.757;
Figure 2. (Continued). at ages e16.5, birth (day 0), and 80 days (WT
and DTA mice) or at 3 days [1 day after injection (inj)], 9 days (7 days
after injection), 25 days (23 days after injection), and 80 days (78 days
after injection) (iDTX mice). (c) Sertoli cell transcript levels (expressed
per testis) in control animals and after Sertoli cell ablation in the fetus
or the neonate; data from individual animals are shown. Cell numbers
and transcript levels in control animals used for fetal (DTA mice) or
neonatal (iDTR mice) ablation were significantly different, and control
groups were not combined for statistical analysis. When significant
differences between groups occurred at each age, these differences
are indicated by a bar and letter at each age: a, effect of fetal
ablation was significant; b, effect of neonatal ablation was significant;
c, effects of fetal ablation and neonatal ablation were both significant.
No bar is shown when there was no significant difference between
groups at that age. Numbers of Sertoli cells in the DTA group
increased significantly (P , 0.05) from birth to 25 days and from
25 days to adulthood. (a and b) The bars represents 100 mm. (b) The
asterisk in the adult DTA mouse section shows a seminiferous tubule
lacking normal spermatogenesis.
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P , 0.001) was also evident between numbers of Sertoli
cells and Leydig cells when an induced reduction in Sertoli
cell number was carried out in the adult [Fig. 5(d)].
Leydig cell morphology in the adult was normal after
fetal ablation of Sertoli cells, but cell volume appeared
reduced after neonatal or adult Sertoli cell ablation [Fig.
6(a)]. This was confirmed by stereological analysis [Fig.
6(b)], which also showed a strong correlation (r = 0.891;
P , 0.001) between Sertoli cell number and Leydig cell
volume after a reduction in Sertoli cell numbers in the
adult [Fig. 6(c)].
No changes in LH or testosterone levels (Supplemental
Fig. 6) were seen after partial ablation of the Sertoli cell
population in the adult, which is consistent with previous
observations from total Sertoli cell ablation studies (9).
Prediction of testicular cell composition using
linear models
Given the strong correlation between Sertoli cell
number and both Leydig cell and germ cell numbers, we
considered the possibility of developing linear models to
predict adult testis cell composition from the number of
Sertoli cells. For both Leydig cell count and germ cell
count, model residuals demonstrated a marked increase
in variance with increasing predicted values, so further
analysis was performed after log transformation of de-
pendent variables (Leydig and germ cell counts) (see
Supplemental Fig. 7 for model residual plots). Model fit
for key models as assessed by Akaike Information Cri-
teria is shown in Supplemental Table 2. The best linear
model of (log) Leydig cell counts included age as a cat-
egory and square root, linear, and squared terms for
Sertoli cell counts (adjusted r2= 0.97). The model had
interactions between age and Sertoli cell number so is
most clearly represented as separate submodels for (log-
transformed) Leydig cell count in each age category (see
Supplemental Table 3a).
Figure 7(a) shows the data for each age category and
the fitted relationship between Sertoli cell number and
Leydig cell number. The leave-one-out cross-validated
predictions for the data set are also shown in Fig. 7(b).
The best model for (log-transformed) germ cell counts
included age as a category and linear and squared terms
for the Sertoli cell counts (adjusted r2 = 0.96). Although
there was no interaction between age group and Sertoli
cell counts, this model is also presented as two submodels
in Supplemental Table 2 for clarity, and comparison with
models for Leydig cell counts. Figure 7(c) shows the fitted
relationship between Sertoli cell number and germ cell
number for each age class. The cross-validated pre-
dictions on the data are shown in Fig. 7(d). The models
show that Sertoli cell number at any age during devel-
opment or in the adult may be used, together with the age
class, as a likely strong predictor of both germ cell and
Leydig cell numbers in the mouse testis.
Discussion
Previous studies have shown that Sertoli cells are critical
for testis differentiation, development, and adult function
(8, 9, 33). They control formation of the seminiferous
Figure 3. Effect of partial ablation of the Sertoli cell population on
the BTB. To determine whether BTB integrity was maintained after
partial ablation of the Sertoli cell population, adult (50 days) iDTR
mice were treated with DTX (10 ng). Testes were injected with
biotin or vehicle (solution containing MgCl2) in vitro, and biotin
infiltration into the tubules was assessed (a) after 7 days or (b) after
30 days. Biotin infiltration into the lumen was seen in some tubules
7 days after DTX injection and, more markedly, 30 days after
injection. However, most tubules were unaffected by partial ablation
of the Sertoli cells (inserts at the bottom right of each figure),
indicating that the remaining cells were able to establish a viable BTB.
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tubules, Leydig cell development, peritubular myoid cell
function, the BTB, and germ cell survival/development.
Most of these functions have been shown in mouse
models through gene knockout or complete cell ablation
studies and so have only limited relevance to common,
real-life problems such as developmental dysfunction or
aging. Dysregulation of development (e.g., through ex-
posure to xenotoxins) or the effects of aging most likely
cause only partial changes in cell number (34, 35); thus, it
is important that we know how such changes can impact
subsequent testis function. In this study, we show that
partial loss of the Sertoli cell population during devel-
opment or in the adult has significant knock-on effects,
changing the Leydig cell number, the germ cell number,
the BTB, and spermatogenesis. The study also identifies a
fundamental relationship between Sertoli cell number,
Leydig cell number, and total germ cell number, which
most likely underpins the development and maintenance
of the adult testis.
The most obvious effect of reducing the size of the fetal
Sertoli cell population was a marked reduction in the
number of testis cords, which was likely due to loss of
basal lamina components secreted by the Sertoli cells
(36). It was reported previously that Sertoli cell numbers
can recover to normal levels by puberty despite an in-
duced reduction in proliferation in utero (28, 37).
However, the loss of testis cords in the DTA model of
Sertoli cell ablation likely restricts the number of Sertoli
cells, which can subsequently develop during the normal
fetal and neonatal proliferative phases (27, 38), and
provides one explanation of why there is no postnatal
catch-up of Sertoli cell numbers.
There was, nevertheless, continued proliferation of
Sertoli cells in these mice beyond the normal period of
mitotic arrest at puberty. This may be related to altered
endocrinology and/or delayed Sertoli cell maturation, al-
though by day 80 levels of Amh (a marker of Sertoli cell
immaturity) were not significantly different from those of
Figure 4. Effects of Sertoli cell ablation on germ cell (GC) number and germ cell/Sertoli cell (GC/SC) ratio in the fetus or neonate. (a and b)
Combined data from studies on fetal and neonatal Sertoli cell ablation showing changes in total GC number and GC/SC ratio in each group
from e16.5 to adulthood. Data from individual animals are shown. Cell numbers in control animals used for fetal or neonatal ablation were
significantly different, and control groups were therefore not combined for statistical analysis. When significant differences between groups
occurred at each age, these differences are indicated by a bar and letter at each age: a, effect of fetal ablation was significant; b, effect of
neonatal ablation was significant; c, effects of fetal ablation and neonatal ablation were both significant. No bar is shown when there was no
significant difference between groups. Note the use of a logarithmic scale for data on GC number and GC/SC ratio. (c) Correlation between total
GC number and Sertoli cell number in adult control mice, DTA mice, and iDTR mice treated with DTX as neonates (Spearman r = 0.800; P ,
0.001; when the fetal ablation group was excluded from the analysis, r = 0.543; P = 0.013). (d and e) Changes in total GC number and GC/SC
ratio after Sertoli cell ablation in the adult. (d) There was a significant correlation (Pearson correlation coefficient, r = 0.915; P , 0.001) between
total GC number and Sertoli cell number, and the best fit line was a second-order polynomial with the equation Y = 38.68X 2 0.0716X2 2 142.4. (e)
GC/SC ratios were assessed by discriminant analysis, and identified groups have been circled where appropriate.
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control animals. No catch-up of the Sertoli cell population
andnoprolongedproliferation past pubertywas seen inmice
after an induced reduction in neonatal Sertoli cell numbers.
This means that the Sertoli cell population is not able to
adjust to late-onset dysregulation, a result consistent with
that of a previous study showing that Sertoli cell numbers do
not recover when postnatal proliferation is altered (34).
Numerous studies have shown that it is possible to
increase Sertoli cell proliferation in the neonatal period
[e.g., through hemicastration, endocrine manipulation,
or gene knockout (e.g., 30, 39, 40)], but increased pro-
liferation does not appear to occur when the population
size is simply reduced after birth. In humans the late stage
of Sertoli cell proliferation occurs shortly before puberty
(3), and the final size of the Sertoli cell population may be
particularly sensitive to alterations during this period.
The direct relationship between spermatid and Sertoli
cell number has been known since Orth et al. (29) showed
Figure 5. Changes in Leydig cell number after a reduction in Sertoli cell number during development or in the adult. (a) Combined data from
studies on fetal and neonatal Sertoli cell ablation show changes in Leydig cell number during development. (b) Changes in Leydig cell transcript
expression after Sertoli cell ablation in the fetus or neonate. (c) Correlation between Leydig cell number and Sertoli cell number in the adult after
fetal or neonatal loss of Sertoli cells (r = 0.929; P , 0.001). (d) Correlation between Leydig cell number and Sertoli cell number after adult loss of
Sertoli cells. The line drawn indicates the best fit constrained to (X = 0, Y = 6.725), which is the mean of the consistent Leydig cell numbers seen
in the absence of Sertoli cells. The curve represents a second-order polynomial best fit with Y = 6.725 + 1.524X 2 0.0253X2 (Pearson correlation
coefficient, r = 0.757; P , 0.001). Data from individual animals are shown. Cell numbers and transcript levels in control animals used for fetal
or neonatal ablation were significantly different, and control groups were therefore not combined for statistical analysis. When significant
differences between groups occurred at each age, these differences are indicated by a bar and letter at each age: a, effect of fetal ablation
was significant and c, effects of fetal ablation and neonatal ablation were both significant. No bar is shown when there was no significant
difference between groups. mRNA, messenger RNA.
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that a reduction in Sertoli cell proliferation in the rat
neonate causes a parallel change in Sertoli cell and
spermatid numbers in the adult. Around the same time, it
was also reported that a strong correlation exists between
Sertoli cell number and spermatid number in adult rats
(41), and it was subsequently shown that increasing
Sertoli cell proliferation in the neonatal period of the rat
or mouse increases spermatid number and maintains the
spermatid/Sertoli cell ratio (30–32).
Studies here have extended this work to confirm that
total germ cell number is also dependent on Sertoli cell
numbers when the Sertoli cell number changes post-
puberty and to formalize the relationship using linear
modeling. In addition, this work shows that the number of
germ cells maintained per Sertoli cell remains constant
even when 60% of Sertoli cells are ablated. Germ cell
development is dependent on the specialized environment
of the seminiferous tubule, and maintenance of the germ
cell/Sertoli cell ratio indicates that the Sertoli cells in the
adult are able to reorganize after a significant reduction in
numbers in such a way that maintains that environment.
This is consistent with the maintenance of the BTB in most
of the observed tubule sections. The spermatogonia/Sertoli
cell ratio may be maintained with more marked loss of
Sertoli cell numbers in the adult because they are not
dependent on the specialized environment of the tubules.
Despite the relative maintenance of germ cell numbers,
however, overall spermatogenesis lost its normal orga-
nization and cell associations after Sertoli cell loss in the
adult, to the extent that staging of the tubules was not
possible. This loss of organization did not prevent de-
velopment and maturation of elongated spermatids,
showing that a degree of flexibility exists in the process.
Interestingly, spermatogenic staging and cell associations
in the adult appeared normal when Sertoli cell ablation
occurred in the neonate. This suggests that the remaining
Sertoli cells are able to adapt during the first wave of
spermatogenesis to achieve and maintain normal orga-
nization of germ cell development and the BTB in
the adult.
During development in mammals, at least two pop-
ulations of Leydig cells develop. Shortly after differen-
tiation of the testes, a fetal population of Leydig cells
forms and is responsible for masculinization of the fetus
(42). Later, between postnatal days 7 and 10 in the
mouse, an adult population of Leydig cells develops,
which exists alongside the fetal population andmaintains
adult androgen levels (43–46). We showed previously
through complete Sertoli cell ablation studies that de-
velopment of the adult population of Leydig cells is de-
pendent on Sertoli cells (9). Results described here now
show that there is a strong correlation between the
Figure 6. Changes in Leydig cell morphology and volume after Sertoli cell ablation. (a) Adult Leydig cell morphology in control animals and after
partial ablation of Sertoli cells in the fetus (DTA mice), neonate (iDTR mice treated with DTX), and adult mice (iDTR mice treated with DTX).
Leydig cell morphology was largely unchanged after fetal Sertoli cell ablation, but there was an apparent decrease in cell volume after neonatal
or adult ablation of Sertoli cells. The bars in these images represent 10 mm. (b) Adult Leydig cell volume measured by the uniform isotropic
random rotator method after Sertoli cell ablation in the fetus (DTA) or neonate (DTX). Data show mean 6 standard error of the mean (n = 6 to
11 animals in each group). *P , 0.05 vs control. (c) Correlation between Leydig cell volume and Sertoli cell number in individual animals after
adult Sertoli cell ablation (r = 0.891; P , 0.001).
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number of Leydig cells that develop in the adult and the
size of the Sertoli cell population. Because the technique
used to manipulate Sertoli cell numbers in this study does
not have a direct effect on the Leydig cells, it is highly
likely that this relationship is causative and implies that
the size of the Sertoli population during development
(both in the fetus and neonate) determines the number of
Leydig cells in the adult.
This newly identified relationship is particularly rel-
evant with respect to our understanding of the control of
testis development and function in the adult, and evi-
dence from previous studies supports the hypothesis. For
example, both Sertoli cell and Leydig cell numbers
are reduced in mice with induced androgen receptor
expression, specifically in the Sertoli cells (47, 48).
Similarly, in mice lacking insulin and insulinlike growth
factor 1 receptors on the Sertoli cells, there is an apparent
proportional decrease in both Sertoli cells and Leydig
cells (49), whereas follicle-stimulating hormone receptor
(FSHR) knockout mice show a reduction in both Sertoli
cell and Leydig cell numbers (50, 51). Leydig cells and
Sertoli cells both increase in nitric oxide synthase 2–null
mice (32), although the nitric oxide synthase 2 deficiency
is not specific to the Sertoli cells in these animals
and could affect both cell types independently. More
tangentially, a correlation exists between Sertoli cell and
Leydig cell numbers in different boar breeds (52).
On the other hand, given that evidence supporting this
relationship between Sertoli cell and Leydig cell numbers
is strong, animal models that do not fit the hypothesis are
of considerable interest because they may point toward
other mechanisms that control Leydig cell numbers. It is
clear, for example, that LH is the primary regulator of
Leydig cell number around puberty because mice that
lack LH or the LH receptor show a marked reduction in
Leydig cell numbers (27, 53, 54). Similarly, a mouse
Figure 7. Development of linear models with which to predict testicular cell composition from Sertoli cell numbers. (a) Data for predicting Leydig
cell number (counts) from Sertoli cell number in three age categories (,21, 21261, and .61 days old). Dotted lines show fitted linear models
that are curved with inflection points because they were fitted to log-transformed Leydig cell counts and include square root and linear and
square terms. (b) Actual Leydig cell number plotted against predicted number from linear models after leave-one-out cross-validation. Points are
colored according to the age category, and the line is an identity line of slope 1.0 and intercept 0. (c) Data for predicting germ cell number from
Sertoli cell number in three age categories (,21, 21245, and .45 days old). Dotted lines show fitted linear models that are curved because they
were fitted to log-transformed Leydig cell counts and include linear and square terms. (d) Actual germ cell number plotted against predicted
number from linear models after leave-one-out cross-validation. Points are colored according to the age category, and the line is an identity line
of slope 1.0 and intercept 0.
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model of Klinefelter syndrome shows an increase in
Leydig cell numbers in the adult (55). It is not known
what happens to Sertoli cell numbers in these animals, but
there is a significant increase in LH that most likely ex-
plains the changes in Leydig cell numbers. In contrast, in
FSH b subunit knockout mice, there is a reduction in
Sertoli cell numbers in the adult but no change in Leydig
cell numbers (50, 51). Because there is a parallel decrease
in both Leydig cells and Sertoli cells in the FSHR
knockout mouse (50, 51), this suggests that constitutive
FSHR activity, which is most likely to be high in FSH b
subunit knockout mice, may be essential for the in-
teraction between Sertoli cells and Leydig cells. In another
animal model, the Follistatinlike 3 (FSTL3) knockout
mouse, an increase has been observed in Sertoli cell
number in the adult with no change in Leydig cell number
(40). Therefore, this may be indicative of a role for FSTL3
in Leydig cell development, which is supported by the
observation that Leydig cell number appears to be in-
creased in FSTL3-overexpressing mice (56).
In addition to enhancing our understanding of testis
development, the relationship between Sertoli cell and
Leydig cell numbers during development may be of some
clinical relevance. Given that there does not appear to be
catch-up growth of the Sertoli cell population and the
critical periods of Sertoli cell proliferation in the human
are in utero and prepuberty (3, 4), exposure to factors
that might affect Sertoli cell proliferation during this
period [e.g., environmental chemicals (34) or fetal nu-
trient restriction (57)] is likely to have knock-on effects,
reducing the adult Leydig cell population size. Con-
versely, treatments that increase Sertoli cell number or
activity are likely to increase the size of the Leydig cell
population. For example, studies of development in a
primate model have shown that pubertal treatment with
follicle-stimulating hormone (FSH) increases Leydig cell
number (58). This effect is likely to be through an increase
in Sertoli cell number and/or cell activity and highlights
the potential importance of FSH in achieving optimal
adult fertility in the adult male (59).
We reported previously that complete ablation of the
adult Sertoli cell population leads to a 75% reduction in
Leydig cell number (8). By using a partial ablation model,
we now show that Leydig cell number in the adult is also
directly correlated with Sertoli cell number. This effect is
more variable than the developmental regulation discussed
previously, and a reduction in Leydig cell number is clearly
seen only when the Sertoli cell population is decreased by
about 50%ormore. Nevertheless, this relationship may be
of importance, particularly during aging, when Sertoli cell
numbers have been shown to decline in some species in-
cluding humans (10–15). The effect of aging on Leydig cell
numbers in humans is less certain; most studies report a
reduction in Leydig cell number with age (15, 60–62),
although a more recent study reports no change (13). This
discrepancy may be because there is considerable variation
in Leydig cell numbers between individuals and because
subject numbers tend not to be large in these studies.
Data relating to aging in other species are limited; in
the horse, there is no change in Sertoli or Leydig cell
numbers with age (63), whereas in the rat, Sertoli cell
numbers decline without a clear effect on Leydig
cell numbers (64, 65). This latter observation may be an
indication that something else is acting to maintain
Leydig cell numbers in the rat, such as increased circu-
lating FSH levels (64, 66). Few other studies are relevant
to this relationship, although Leydig cell apoptosis is
reported to occur after Sertoli cell loss in BCLW-deficient
mice (67), whereas the seasonal increase in Leydig cell
number in the horse is preceded by an increase in Sertoli
cell number (68). A relationship between Sertoli and
Leydig cell numbers would also explain what limits adult
Leydig cell population size, which is consistent through
normal adult life and which returns to exactly pre-
treatment levels in rats after complete ablation with
ethane dimethane sulfonate (69, 70).
In this study, altered Sertoli cell number was also
closely associated with changes in Leydig cell volume.
This relationship has also been seen during aging in both
rats and humans (61, 64, 65) and suggests a Sertoli
cell2regulated change in cell function. Reduced cell
volume is normally associated with reduced cell activity,
although circulating testosterone levels are maintained in
these animals; this would suggest an increase in Leydig
cell activity as the total number of Leydig cells is reduced.
This is consistent with the increase in Cyp11a1 seen
previously in Leydig cells after Sertoli cell ablation (9),
but it leaves open the question of why cell volume de-
clines. There are a number of possible explanations, such
as direct loss of Sertoli cell stimulation or indirect effects
through changes in testicular vasculature after Sertoli cell
ablation (6). Interestingly, normal Leydig cell volumewas
seen after fetal Sertoli cell ablation, which indicates either
that the cells are able to adapt to loss of the Sertoli cells or
that vascular development at this stage is sufficiently
flexible to ensure normal capillary development in the
interstitial tissues. During aging, there is increased vas-
cular dysfunction in the testis (71), so the change in
Leydig cell volume during aging may also occur because
of reduced vascularization brought about by loss of
Sertoli cells. Leydig cell volume can also be regulated
directly by circulating LH (72), although this is unlikely
to explain aging effects, as LH levels are either unchanged
during aging [rat (65)] or are increased [human (73)].
This study shows that dysregulation of fetal or neo-
natal testis development can have major knock-on effects
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on cell numbers in the adult testis and that Sertoli cell
number cannot recover from dysregulation during the
neonatal phase. Interestingly, however, there is enough
flexibility during development of the testis to allow the
establishment of qualitatively normal spermatogenesis in
the adult despite significant loss of Sertoli cells during
development. Results from this study also describe the
fundamental relationship that exists between Sertoli cell,
Leydig cell, and germ cell numbers during development
and in the adult testis. This relationship can be circum-
vented by changes in hormone levels but, under normal
circumstances, is most likely to regulate both Leydig and
germ cell numbers in the adult and during aging. Given
the critical role that the Leydig cells play in both fertility
and adult health through secretion of testosterone (74),
identification of the mechanism linking adult Sertoli cell
and Leydig cell populations is of considerable importance
in understanding testis development and adult function.
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